Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial
Year: 2025
Type: article
Language: en
Topic: Neuroendocrine Tumor Research Advances
Authors and affiliations:
raw_author_name: Maciej Kolodziej
raw_affiliation_strings: Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland
raw_author_name: Marta Opalinska
raw_affiliation_strings: Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
raw_author_name: Renata Mikolajczak
raw_affiliation_strings: Radioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Poland
raw_author_name: Alicja Hubalewska-Dydejczyk
raw_affiliation_strings: Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
raw_author_name: Marek Dedecjus
raw_affiliation_strings: Department of Endocrine Oncology and Nuclear Medicine, National Institute of Oncology - National Research Institute, Warsaw, Poland
raw_author_name: Aldona Kowalska
raw_affiliation_strings: Collegium Medicum, Jan Kochanowski University, Kielce, Poland
raw_author_name: Marek Saracyn
raw_affiliation_strings: Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland
Faculty of Medicine, University of Warsaw, Warsaw, Poland
raw_author_name: Piotr Garnuszek
raw_affiliation_strings: Radioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Poland
raw_author_name: Izabela Cieszykowska
raw_affiliation_strings: Radioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Poland
raw_author_name: Joanna Januszkiewicz-Caulier
raw_affiliation_strings: Department of Endocrine Oncology and Nuclear Medicine, National Institute of Oncology - National Research Institute, Warsaw, Poland
raw_author_name: Joanna Dlugosinska
raw_affiliation_strings: Department of Endocrine Oncology and Nuclear Medicine, National Institute of Oncology - National Research Institute, Warsaw, Poland
raw_author_name: Adam Daniel Durma
raw_affiliation_strings: Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland
Faculty of Medicine, University of Warsaw, Warsaw, Poland
raw_author_name: Katarzyna Jozwik-Plebanek
raw_affiliation_strings: Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland
raw_author_name: Adrianna Mroz
raw_affiliation_strings: Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland
Faculty of Medicine, University of Warsaw, Warsaw, Poland
raw_author_name: Katarzyna Janiak
raw_affiliation_strings: Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland
raw_author_name: Danuta Gasior-Perczak
raw_affiliation_strings: Collegium Medicum, Jan Kochanowski University, Kielce, Poland
raw_author_name: Malgorzata Trofimiuk-Muldner
raw_affiliation_strings: Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
raw_author_name: Anna Sowa-Staszczak
raw_affiliation_strings: Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
raw_author_name: Janusz Braziewicz
raw_affiliation_strings: Department of Nuclear Medicine, Holy Cross Cancer Center, Kielce, Poland
raw_author_name: Wioletta Lenda-Tracz
raw_affiliation_strings: Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland
raw_author_name: Krzysztof Kacperski
raw_affiliation_strings: Department of Nuclear Medicine, Military Institute of Medicine - National Research Institute, Warsaw, Poland
Particle Acceleration Physics and Technology Division, National Centre for Nuclear Research, Otwock, Poland
raw_author_name: Anna Budzynska
raw_affiliation_strings: Department of Nuclear Medicine, Military Institute of Medicine - National Research Institute, Warsaw, Poland
raw_author_name: Agata Kubik
raw_affiliation_strings: Department of Nuclear Medicine, Military Institute of Medicine - National Research Institute, Warsaw, Poland
raw_author_name: Patrycja Pastusiak
raw_affiliation_strings: Department of Nuclear Medicine, Military Institute of Medicine - National Research Institute, Warsaw, Poland
raw_author_name: Wioletta Chalewska
raw_affiliation_strings: Department of Endocrine Oncology and Nuclear Medicine, National Institute of Oncology - National Research Institute, Warsaw, Poland
raw_author_name: Anna Borkowska
raw_affiliation_strings: Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland
raw_author_name: Paulina Cegla
raw_affiliation_strings: Department of Endocrine Oncology and Nuclear Medicine, National Institute of Oncology - National Research Institute, Warsaw, Poland
raw_author_name: Agata Walecka-Mazur
raw_affiliation_strings: Department of Endocrinology, Holy Cross Cancer Center, Kielce, Poland
raw_author_name: Artur Szczodry
raw_affiliation_strings: Department of Endocrinology, Holy Cross Cancer Center, Kielce, Poland
raw_author_name: Grzegorz Kaminski
raw_affiliation_strings: Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland